Jobs / United States / Pfizer INC
Integrated Evidence Generation Therapeutic Area Lead, Inflammation & Immunology
Pfizer INC · 🇺🇸 5 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
Role Purpose Lead Inflammation & Immunology Therapeutic Area evidence strategy and delivery by integrating IEP, RWE/Epi, patient-centered research, and cross-functional execution to maximize product, medical, regulatory, access, and patient impact. Role Summary • Own TA integrated evidence strategy and execution across the product lifecycle. • Connect IEP, RWE/Epi, patient-centered research, external research, and study delivery. • Partner with TA Medical teams, TA Research Units, the CMO organization (Regulatory, Safety, DS&A, Medical Enablement & Quality, Legal/Compliance, and Research Units. • Champion innovations in evidence generation, methods, and AI/ML. • Accountable for quality, timeliness, efficiency, and strategic value of evidence deliverables. • Build internal/external partnerships and measure impact through metrics, scorecards, and operating frameworks. Role Responsibilities • Shape and execute enterprise-wide strategy, providing visionary leadership and sound judgment to drive business performance and long-term impact. • Establish external and internal scientific leadership in RWE, epidemiology, evidence generation, and data science innovation. • Influence critical decisions across global functions and external stakeholder groups, including regulators, HTAs, payers, experts, and strategic partners. • Build and sustain organizational capability through exceptional talent leadership, succession planning, and development of diverse teams. • Ensure operational excellence by fostering a culture of accountability, agility, innovation, and trusted leadership while delivering measurable outcomes. Qualifications • Advanced degree required: MD, PhD, MS, or equivalent in Epidemiology, Outcomes Research, Medicine, Public Health, Statistics, or related discipline. • 15+ years of relevant pharmaceutical, academic, medical, or evidence-generation experience; 15+ years preferred for enterprise/portfolio leadership. • Demonstrated success leading multidisciplinary scientific teams in complex matrix environments. • Experience shaping evidence strategy and delivering late-phase, post-approval, RWE/Epi, or integrated medical evidence programs. • Knowledge of regulatory evidence expectations and engagement with FDA, EMA, MHRA, or other global agencies preferred. • Experience using common AI tools, including generative technologies such as ChatGPT or Microsoft Copilot, to support problem solving and enhance productivity. • Demonstrated curiosity for exploring how these tools can improve outcomes and understanding of responsible AI practices, including risk management and ethical use. Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact. This is a hybrid role requiring you to live within commuting distance and work on-site an average of 2.5 days per week or more as needed. Posting end date: October 28, 2026 The annual base salary for this position ranges from $274,000.00 to $456,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 30.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical